Health Prob Civil. 2023; 17(4): 299-305
1. Sipka S. [The current prevalence of allergy and the possibility of its treatment in Debrecen]. Debreceni Szemle. 2016; 24(4): 429-436 (in Hungarian).
2.
Lucas JM. Microarrays: molecular allergology and nanotechnology for personalised medicine (I). Allergol Immunopathol (Madr). 2010; 38(3): 153-161. https://doi:10.1016/j.aller.2010.03.001
3.
Csima E, Cserháti E, Mezei Gy. [Oral allergy syndrome in childhood]. LAM. 2011; 21(6-7): 451-457 (in Hungarian).
4.
Carlson G, Coop C. Pollen food allergy syndrome (PFAS): A review of current available literature. Ann Allergy Asthma Immunol. 2019; 123(4): 359-365. https://doi.org/10.1016/j.anai.2019.07.022
5.
Bentrad S, Collin S, Brocart C, Pietrement C, Sabouraud D. Peanut or hazelnut? About two cases of severe anaphylaxis to hazelnut involving PR-10. World Allergy Organization J. 2020; 13(8): 192. https://doi.org/10.1016/j.waojou.2020.100294
6.
Kleine-Tebbe J, Wangorsch A, Vogel L, Crowell DN, Haustein U-F, Vieths S. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1-related PR-10 protein in soybean, SAM22. J Allergy Clin Immunol. 2002; 110(5): 797-804. https://doi.org/10.1067/mai.2002.128946
7.
Senders AS, Oropeza AR, Kristensen B, Eller E, Kjaer HF, Bindslev-Jensen C, et al. Food-dependent exerciseinduced anaphylaxis due to almond in a PR-10–sensitized patient. The J Allergy Clin Immunol: In Practice. 2018; 6(2): 683-684. https://doi.org/10.1016/j.jaip.2017.12.018
8.
Calamelli E, Trozzo A, Di Blasi E, Serra L, Bottau P. Hazelnut Allergy. Medicina. 2021; 57(1): 67. https://doi.org/10.3390/medicina57010067
9.
Integrated Taxonomic Information System [Internet]. [access 2022 Jul 19]. Available from: https://www.itis.gov/servlet/SingleRpt/SingleRpt?search_topic=TSN&search_value=501642#null
10.
Hofmann C, Scheurer S, Rost K, Graulich E, Jamin A, Foetisch K, et al. Cor a 1–reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen–associated food allergy to hazelnut. J Allergy Clin Immunol. 2013; 131(5): 1384-1392. https://doi.org/10.1016/j.jaci.2012.10.037
11.
De Knop KJ, Verweij MM, Grimmelikhuijsen M, Philipse E, Hagendorens MM, Bridts CH, et al. Age-related sensitization profiles for hazelnut (Corylus avellana) in a birch-endemic region. Pediatr Allergy Immunol. 2011; 22(1): 139-149. https://doi.org/10.1111/j.1399-3038.2011.01112.x
12.
Inoue Y, Sato S, Takahashi K, Yanagida N, Yamamoto H, Shimizu N, et al. Component-resolved diagnostics can be useful for identifying hazelnut allergy in Japanese children. Allergol Int. 2020; 69(2): 239-245. https://doi.org/10.1016/j.alit.2019.10.001
13.
Erhard SM, Bellach J, Yürek S, Tschirner S, Trendelenburg V, Grabenhenrich LB, et al. Primary and pollenassociated hazelnut allergy in school-aged children in Germany: a birth cohort study. Allergol Int. 2021; 70(4): 463-470. https://doi.org/10.1016/j.alit.2021.05.006
14.
Kleine-Tebbe J, Jakob T. Molecular allergy diagnostics. Switzerland: Springer International Publishing; 2017.
15.
McWilliam V, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The prevalence of tree nut allergy: a systematic review. Curr Allergy Asthma. 2015; 15(54). https://doi.org/10.1007/s11882-015-0555-8
16.
Datema MR, van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, et al. Component-resolved diagnosis and beyond: multivariable regression models to predict severity of hazelnut allergy. Allergy. 2018; 73(3): 549-559. https://doi.org/10.1111/all.13328
17.
Datema MR, Zuidmeer-Jongejan L, Asero R, Barreales L, Belohlavkova S, de Blay F, et al. Hazelnut allergy across Europe dissected molecularly: a EuroPrevall outpatient clinic survey. J Allergy Clin Immunol. 2015; 136(2): 382-391. https://doi.org/10.1016/j.jaci.2014.12.1949
18.
Ciprandi G, Pistorio A, Silvestri M, Rossi GA, Tosca MA. Hazelnut anaphylaxis: the usefulness of molecularbased allergy diagnostics. Rev Fr Allergol. 2015; 55(2): 100-102. https://doi.org/10.1016/j.reval.2014.09.005
19.
Hansen KS, Ballmer-Weber BK, Sastre J, Lidholm J, Andersson K, Oberhofer H, et al. Component-resolved in vitro diagnosis of hazelnut allergy in Europe. J Allergy Clin Immunol. 2009; 123(5): 1134-1141. https://doi.org/10.1016/j.jaci.2009.02.005
20.
Valcour A, Lidholm J, Borres MP, Hamilton RG. Sensitization profiles to hazelnut allergens across the United States. Ann Allergy Asthma Immunol. 2019; 122(1): 111-116. https://doi.org/10.1016/j.anai.2018.09.466.
21.
Buyuktiryaki B, Cavkaytar O, Sahiner UM, Yilmaz EA, Yavuz ST, Soyer O, et al. Cor a 14, Hazelnut-Specific IgE, and SPT as a reliable tool in hazelnut allergy diagnosis in Eastern Mediterranean children. J Allergy Clin Immunol: In Practice. 2016; 4(2): 265-272. https://doi.org/10.1016/j.jaip.2015.12.012
22.
Masthoff LJN, Mattsson L, Zuidmeer-Jongejan L, Lidholm J, Andersson K, Akkerdaas JH, et al. Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. J Allergy Clin Immunol. 2013; 132(2): 393-399. https://doi.org/10.1016/j.jaci.2013.02.024
23.
Masthoff LJN, Blom WM, Rubingh CM, Klemans RJB, Remington BC, Bruijnzeel-Koomen CAFM, et al. Sensitization to Cor a 9 or Cor a 14 has a strong impact on the distribution of thresholds to hazelnut. J Allergy Clin Immunol. In Practice. 2018; 6(6): 2112-2114. https://doi.org/10.1016/j.jaip.2018.04.040
24.
Blanc F, Bernard H, Ah-Leung S, Przybylski-Nicaise L, Skov PS, Purohit A, et al. Further studies on the biological activity of hazelnut allergens. Clin Transl Allergy. 2015; 5(26). https://doi.org/10.1186/s13601-015-0066-7
25.
Foong R-X, Dantzer JA, Wood RA, Santos AF. Improving diagnostic accuracy in food allergy. J Allergy Clin Immunol In Practice. 2021; 9(1): 71-80. https://doi.org/10.1016/j.jaip.2020.09.037
Copyright: © 2023 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
